Last reviewed · How we verify

NCT06009211

Impact of Aromatherapy on Nausea in Hospitalized Children Undergoing Rehabilitation

ENROLLING BY INVITATION Last updated 18 July 2024
What this trial tests

trial testing QueaseEase in Nausea in 10 participants. Enrolling by invitation.

Timeline
23 January 2024
Primary endpoint
1 May 2026
1 May 2027

Quick facts

Lead sponsorArkansas Children's Hospital Research Institute
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment10
Start date23 January 2024
Primary completion1 May 2026
Estimated completion1 May 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Arkansas Children's Hospital Research Institute

Who can join

Adults 8 to 17, any sex, with Nausea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children, ages 8 - 17, will be enrolled in a research study about the impact of aromatherapy on nausea in the pediatric rehabilitation unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nausea

Currently open trials in the same condition.

Other Arkansas Children's Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06009211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing